首页 | 本学科首页   官方微博 | 高级检索  
     

糖皮质类固醇激素治疗急性肺损伤的进展
引用本文:刘庆,吴珊. 糖皮质类固醇激素治疗急性肺损伤的进展[J]. 国外医学:内科学分册, 2008, 35(1): 41-45
作者姓名:刘庆  吴珊
作者单位:贵阳医学院,贵州贵阳,550004;贵阳医学院,贵州贵阳,550004
摘    要:
急性肺损伤(ALI)是全身炎症反应综合征在肺部的表现,炎症失控是其病变本质。糖皮质类固醇激素因其抗炎和免疫抑制特性而被广泛应用于临床重症疾病。本文在复习近年来文献的基础上就糖皮质激素在ALI中的应用进展作一综述。

关 键 词:急性肺损伤  全身炎症反应综合征  糖皮质类固醇激素
文章编号:1004-2369(2008)01-0041-05
收稿时间:2007-08-06
修稿时间:2007-10-10

The therapeutic advancement of glucocorticoid on acute lung injury
LIU Qing,WU Shan. The therapeutic advancement of glucocorticoid on acute lung injury[J]. Foreign Medical Sciences(Section of Internal Medicine), 2008, 35(1): 41-45
Authors:LIU Qing  WU Shan
Abstract:
Acute lung injury is a reflect of systemic inflammatory response syndrome on lung,and its nature is the out of control in inflammatory reaction of body.Glucocorticoid is widely used in clinic because of its anti-inflammatory and immune inhibitory effect.Now we have this article to review the therapeutic advancement of glucocorticoid used in acute lung injury.
Keywords:Acute lung injury  Systemic inflammatory response syndrome  Glucocorticoid
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号